Novo Nordisk shares shrug off concerns over study linking weight loss drugs to rare eye condition

July 4, 2024 admin-dominor

[ad_1]

Novo Nordisk investors appeared unperturbed Thursday by a critical Harvard report that linked weight loss drugs to a rare eye condition.

[ad_2]

Source link

Contrasting emotions for Turkey’s Dutch-born contingent
The hidden ‘eagle’s nest’ city that Alexander the Great couldn’t conquer | CNN

You May Also Like

Harvard nutritionist: The No. 1 ultra-processed food I never buy—and what I eat instead

How to invest $1 million for the next decade, according to private bankers and wealth advisors

Study links talc use to ovarian cancer — a potential boon for thousands suing J&J